Alnylam Pharmaceuticals Inc. (ALNY): Price and Financial Metrics

ALNY POWR Grades

• Sentiment is the dimension where ALNY ranks best; there it ranks ahead of 89.75% of US stocks.
• ALNY's strongest trending metric is Growth; it's been moving up over the last 179 days.
• ALNY ranks lowest in Stability; there it ranks in the 35th percentile.

ALNY Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for ALNY is -4.41 -- better than just 3.23% of US stocks.
• With a price/sales ratio of 20.25, ALNYLAM PHARMACEUTICALS INC has a higher such ratio than 94.4% of stocks in our set.
• ALNY's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.65% of US stocks.
• Stocks that are quantitatively similar to ALNY, based on their financial statements, market capitalization, and price volatility, are STX, CYTK, GDDY, ICPT, and CLNN.
• ALNY's SEC filings can be seen here. And to visit ALNYLAM PHARMACEUTICALS INC's official web site, go to www.alnylam.com.

ALNY Valuation Summary

• In comparison to the median Healthcare stock, ALNY's price/sales ratio is 309.8% higher, now standing at 20.9.
• Over the past 231 months, ALNY's price/earnings ratio has gone down 19.1.

Below are key valuation metrics over time for ALNY.

ALNY Growth Metrics

Its 3 year net income to common stockholders growth rate is now at -11.3%.
• The 3 year cash and equivalents growth rate now stands at -26.33%.
• Its year over year price growth rate is now at 2.48%.

ALNY's revenue has moved up $288,104,000 over the prior 15 months.

The table below shows ALNY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	1,037.418	-541.274	-1,131.156
2022-09-30	960.918	-559.437	-1,182.123
2022-06-30	884.245	-578.189	-980.717
2022-03-31	879.98	-577.226	-892.874
2021-12-31	844.287	-641.693	-852.824
2021-09-30	749.314	-614.696	-837.904

ALNY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALNY has a Quality Grade of C, ranking ahead of 30.65% of graded US stocks.
• ALNY's asset turnover comes in at 0.22 -- ranking 188th of 681 Pharmaceutical Products stocks.
• QGEN, TXMD, and KMDA are the stocks whose asset turnover ratios are most correlated with ALNY.

The table below shows ALNY's key quality metrics over time.